ChemicalBook > CAS DataBase List > 5-(2-formyl-3-hydroxyphenoxy)valeric acid

5-(2-formyl-3-hydroxyphenoxy)valeric acid

Product Name
5-(2-formyl-3-hydroxyphenoxy)valeric acid
CAS No.
77858-21-0
Chemical Name
5-(2-formyl-3-hydroxyphenoxy)valeric acid
Synonyms
BW 12C;BW12C79;BW 12C79;BW-12C79;5-(2-formyl-3-hydroxyphenoxy)valeric acid;5-(2-Formyl-3-hydroxyphenoxy)pentanoic acid;Pentanoic acid, 5-(2-formyl-3-hydroxyphenoxy)-;VELARESOL; BW 12C79; BW-12C79; BW12C79; BW 12C; BW-12C; BW12C
CBNumber
CB1922154
Molecular Formula
C12H14O5
Formula Weight
238.24
MOL File
77858-21-0.mol
More
Less

5-(2-formyl-3-hydroxyphenoxy)valeric acid Property

storage temp. 
Store at -20°C
solubility 
DMF: 16 mg/mL,DMSO: 10 mg/mL,Ethanol: Slightly soluble
form 
A solid
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
API0010572
Product name
5-(2-FORMYL-3-HYDROXYPHENOXY)PENTANOIC ACID
Purity
95.00%
Packaging
5MG
Price
$503.15
Updated
2021/12/16
DC Chemicals
Product number
DC10682
Product name
Velaresol
Purity
>98%
Packaging
100mg
Price
$450
Updated
2021/12/16
More
Less

5-(2-formyl-3-hydroxyphenoxy)valeric acid Chemical Properties,Usage,Production

Originator

Velaresol ,Wellcome (GSK)

Manufacturing Process

1st method of preparation of 5-(2-formyl-3-hydroxyphenoxy) pentanoic acid:
(A) 5-(2-Formyl-3-methoxyphenoxy)pentanoic acid:
2-Hydroxy-6-methoxybenzaldehyde (16.875 g, 0.111 M), ethyl 5- bromopentanoate (23.25 g, 17.6 ml, 0.111 M), anhydrous potassium carbonate (16.5 g), sodium iodide (0.675 g) and 95% ethanol (150 ml) were refluxed with stirring (16 hours). The cooled reaction mixture was filtered and the solid washed well with ethanol. The filtrate was evaporated to dryness and the residue partitioned between ether and water. The ethereal layer was separated and washed with 2 N sodium hydroxide solution, water, dried (sodium sulfate) and evaporated. The residue was dissolved in 95% ethanol (300 ml) and 0.66 N sodium hydroxide solution (450 ml) and stirred at ambient temperature (4 hours). The reaction mixture was evaporated to half volume and diluted with water. The mixture was extracted once with ether and the aqueous layer acidified with concentrated hydrochloric acid with cooling. The crystalline solid formed was filtered off and washed well with water. Recrystallisation from ethyl acetate-petrol gave 5-(2-formyl-3- methoxyphenoxy)pentanoic acid, melting point 99-101°C.
(B) 5-(2-Formyl-3-hydroxyphenoxy)pentanoic acid: 5-(2-Formyl-3-methoxyphenoxy)pentanoic acid (504 mg, 0.002 M) was dissolved in anhydrous dichloromethane (20 ml) and cooled to -70°C. A solution of boron trichloride in anhydrous dichloromethane (0.25 g/ml, 3.76 ml) was added dropwise over 10 min and the mixture stirred at -70°C (15 min). The reaction mixture was allowed to reach ambient temperature and stirred at that temperature (1.25 hours). After cooling to 10°C, 10% sodium acetate solution (15 ml) was added dropwise with stirring so that the temperature did not rise above 15°C. The resulting mixture was diluted with ethyl acetate (50 ml) and filtered. The filtrate was transferred to a separating funnel and the aqueous layer separated. The organic phase was extracted with 10% sodium carbonate solution (2 x 50 ml), the combined extracts acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The combined extracts were washed with water, dried (sodium sulfate) and evaporated to give a crystalline solid. This solid was dissolved in the minimum of chloroform-methanol (95:5) and passed through a pad of Kieselgel G. Evaporation of the filtrate and recrystallization from benzene-petrol gave 5-(2- formyl-3-hydroxyphenoxy)pentanoic acid, melting point 97-99°C.
2nd method of preparation of 5-(2-formyl-3-hydroxyphenoxy)pentanoic acid:
(A) Ethyl 5-(2-formyl-3-benzyloxypheoxy)pentanoate:
A mixture of 2-hydroxy-6-benzyloxybenzaldehyde (3.0 g, 0.013 M), ethyl 5- bromopentanoate (2.75 g, 0.013 M), anhydrous potassium carbonate (2.16 g, 0.0156 M), sodium iodide (0.195 g) and dry dimethylformamide (15 ml) were stirred at 60-80°C for 3 hours and then left to stir at room temperature overnight. The mixture was then poured into water (50 ml) and the product extracted with ether (2 x 80 ml) and the combined extracts washed with 10% aqueous sodium hydroxide (2 x 20 ml) and then with water to neutrality, dried, and evaporated to give ethyl 5-(2-formyl-3- benzyloxyphenoxy)pentanoate, (4.0 g, 86%) as a pale yellow oil.
(B) 5-(2-Formyl-3-benzyloxyphenoxy)pentanoic acid:
A mixture of ethyl 5-(2-formyl-3-benzyloxyphenoxy)pentanoate (3.61 g, 0.01 M), potassium hydroxide (1.19 g, 0.021 M) and ethanol (40 ml) were stirred at 50°-60°C for 5 hours. The ethanol was then removed in vacuum, the residue dissolved in water (50 ml) and the solution extracted with ether (2 x 80 ml). The aqueous layer was then acidified by the addition of 2 N aqueous hydrochloric acid and the product extracted with ether, and the combined extracts washed with water to neutrality, dried, and concentrated in vacuum to give 5-(2-formyl-3-benzyloxyphenoxy)pentanoic acid, 3.0 g, 91% as a yellow oil which crystallized on standing. The crude solid was crystallized from benzene/petroleum ether to give pale cream crystals, melting point 110°C.
(C) 5-(2-Formyl-3-hydroxyphenoxy)pentanoic acid:
A solution of 5-(2-formyl-3-benzyloxyphenoxy)pentanoic acid (1.0 g, 0.003 M) in ethanol containing 5% palladium on charcoal catalyst (0.61 g) was hydrogenated at atmospheric pressure. After 20 min the reaction was complete and the catalyst was filtered off and the ethanol removed in vacuum to give 5-(2-formyl-3-hydroxyphenoxy)pentanoic acid, m.p. 94°C.
3rd method of preparation of 5-(2-formyl-3-hydroxyphenoxy)pentanoic acid:
(A) Ethyl 5-(2-formyl-3-methoxyphenoxy)pentanoate:
2-Hydroxy-6-methoxybenzaldehyde (26.0 g, 0.17 M), ethyl 5- bromopentanoate (27.1 ml, 0.17 M), anhydrous potassium carbonate (25.4 g), sodium iodide (1.04 g) and ethanol (230 ml) were refluxed with stirring for 16 hours. The cooled reaction mixture was filtered and the solid washed well with ethanol. The filtrate was evaporated to dryness and the residue partitioned between ether (200 ml) and water (200 ml). The organic layer was separated and washed with 2 N sodium hydroxide solution, water, brine, dried (magnesium sulfate) and evaporated to yield ethyl 5-(2-formyl-3- methoxyphenoxy)pentanoate 32.97 g, 67% yield, as a pale yellow oil that solidified on standing in the refrigerator.
(B) 5-(2-Formyl-3-hydroxyphenoxy)pentanoic acid:
10 ml of a solution of iodine (40.3 g, 0.157 M) in ether (sodium dry, 500 ml) was added to a stirred mixture of magnesium metal (15.4 g, 0.636 GATOM) and ether (50 ml). When the reaction had commenced the remainder of the iodine solution was added dropwise at such a rate as to cause gentle refluxing. After the addition was complete the reaction mixture was heated to reflux until a colorless solution was obtained (1/2 hour). The cooled reaction mixture was filtered and the unreacted magnesium metal was washed with ether (100 ml). The colorless solution of magnesium iodide thus obtained was added dropwise to a solution of ethyl 5-(2-formyl-3- methoxyphenoxy)pentanoate (30.0 g, 0.106 M) in tetrahydrofuran (dried over molecular sieve, 300 ml) at such a rate as to cause gentle refluxing. A fine yellow precipitate dropped out of solution. The mixture was brought to reflux with stirring for 5 hours. The cooled reaction mixture was poured into 10% hydrochloric acid (400 ml). The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The combined organic phases, containing ethyl 5-(2-formyl-3-hydroxyphenoxy)pentanoate, were washed with water and then extracted into 2 N sodium hydroxide solution. The combined aqueous extracts were acidified with concentrated hydrochloric acid with ice- cooling. The precipitate was filtered, washed with water, sucked dry and then quickly washed with a petrol/ethanol mixture (6:1, 60 ml) to remove some of the color. The crude product was dried in a desiccator over phosphorus pentoxide to give a dark-peach colored solid which was then dissolved in ethyl acetate (250 ml); aluminum oxide (neutral, 10 g) and charcoal (5.0 g) were added and the mixture stirred vigorously for 1/2 hour and then filtered to give a pale-yellow solution. The solvent was removed in vacuum to give 5-(2- formyl-3-hydroxyphenoxy)pentanoic acid, melting point 98-99°C (from ethyl acetate/petrol).

Therapeutic Function

Antianemic

5-(2-formyl-3-hydroxyphenoxy)valeric acid Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

5-(2-formyl-3-hydroxyphenoxy)valeric acid Suppliers

Shanghai JiYi Biotechnology Co. Ltd.
Tel
13621943973
Fax
-
Email
sales@shjiyipharmatech.com
Country
China
ProdList
1166
Advantage
55
Shanghai Chaolan Chemical Technology Center
Tel
QQ:65489617 15618227136
Fax
21-5161 9052
Email
info@SuperLan-chem.com
Country
China
ProdList
9737
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131981
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Fax
010-60605840
Email
psaitong@jm-bio.com
Country
China
ProdList
12308
Advantage
58
Medi-tech Bioscientific Co., Ltd.
Tel
0519-83246372 13585352506
Fax
0519-83246372
Country
China
ProdList
1844
Advantage
58
Nanjing KaiMubo Pharmaceutical Co., Ltd.
Tel
025-66162170
Fax
025-66162170
Country
China
ProdList
7183
Advantage
55
Angel Pharmatech, Ltd.
Tel
17317130613
Fax
QQ3358272972
Email
3358272972@qq.com
Country
China
ProdList
3238
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6393
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 15093356674;
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30255
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9414
Advantage
58

77858-21-0, 5-(2-formyl-3-hydroxyphenoxy)valeric acidRelated Search:


  • 5-(2-formyl-3-hydroxyphenoxy)valeric acid
  • BW 12C
  • 5-(2-Formyl-3-hydroxyphenoxy)pentanoic acid
  • BW12C79
  • BW-12C79
  • VELARESOL; BW 12C79; BW-12C79; BW12C79; BW 12C; BW-12C; BW12C
  • BW 12C79
  • Pentanoic acid, 5-(2-formyl-3-hydroxyphenoxy)-
  • 77858-21-0